Evidence map›Paper›PMID 25930054›Full record

ArticleEuropean journal of epidemiology2016

Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.

Emanuele Leoncini, Valeria Edefonti, Mia Hashibe, Maria Parpinel, Gabriella Cadoni, Monica Ferraroni, Diego Serraino, Keitaro Matsuo, Andrew F Olshan, Jose P Zevallos and 16 more

Open access · greenAbstract read
In one paragraph

Article in European journal of epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Lifestyle-Based Approaches to Cancer Prevention and Treatment: Diet, Physical Activity, and Integrative Strategies.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Cancer Prevention and Treatment Based on Lifestyles.Cancer treatment and research · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 6 countries.

Emanuele LeonciniSection of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Largo F. Vito, 1, 00168, Rome, Italy.
Valeria EdefontiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Mia HashibeDivision of Public Health, Department of Family and Preventive Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Maria ParpinelDepartment of Medical and Biological Sciences, Institute of Hygiene and Epidemiology, University of Udine, Udine, Italy.
Gabriella CadoniInstitute of Otorhinolaryngology, Università Cattolica del Sacro Cuore, Rome, Italy.
Monica FerraroniDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Diego SerrainoAviano Cancer Centre, Aviano, Italy.
Keitaro MatsuoFaculty of Medical Sciences, Kyushu University, Kyushu, Japan.
Andrew F OlshanSchool of Public Health, University of North Carolina, Chapel Hill, NC, USA.
Jose P ZevallosSchool of Public Health, University of North Carolina, Chapel Hill, NC, USA.
Deborah M WinnNational Cancer Institute, Bethesda, MD, USA.
Kirsten MoysichRoswell Park Cancer Institute, Buffalo, NY, USA.
Zuo-Feng ZhangUCLA School of Public Health, Los Angeles, CA, USA.
Hal MorgensternDepartments of Epidemiology and Environmental Health Sciences, School of Public Health and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
Fabio LeviInstitut Universitaire de Medecine Sociale et Preventive (IUMSP), Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Karl KelseyBrown University, Providence, RI, USA.
Michael McCleanBoston University School of Public Health, Boston, MA, USA.
Cristina BosettiDepartment of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Itlay.
Stimson SchantzNew York Eye and Ear Infirmary, New York, NY, USA.
Guo-Pei YuMedical Informatics Center, Peking University, Beijing, China.
Paolo BoffettaThe Tisch Cancer Institute and Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Yuan-Chin Amy LeeDivision of Public Health, Department of Family and Preventive Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Shu-Chun ChuangInstitute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
Adriano DecarliDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Stefania BocciaSection of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Largo F. Vito, 1, 00168, Rome, Italy. sboccia@rm.unicatt.it.
University of Milan · ITUniversità Cattolica del Sacro Cuore · ITHuntsman Cancer Institute · USUniversity of North Carolina at Chapel Hill · USBoston University · USCentro di Riferimento Oncologico · ITJohn Brown University · USKyushu University · JPMario Negri Institute for Pharmacological Research · ITNational Health Research Institutes · TWNational Institutes of Health · USNew York Eye and Ear Infirmary · USPeking University · CNRoswell Park Comprehensive Cancer Center · USTisch Hospital · USUniversity of California, Los Angeles · USUniversity of Lausanne · CHUniversity of Michigan–Ann Arbor · USUniversity of Udine · IT

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
The Boston Collaborative Oral Cancer StudyR01CA078609 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1999 to 2010
$5.3M
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERSU01CA096134 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAO, JENNY T · 2002 to 2007
$5.1M
Patterns of Somatic Gene Alterations in Oral CancerR01CA100679 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 2004 to 2012
$2.6M
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERSR01DA011386 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1999 to 2003
$1.8M
Molecular Epidemiology and Gene-Environment InteractionR21ES011667 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 2002 to 2004
$651k
Pooled Analyses of SNPs and Risk of Head &Neck CancerR03DE016611 · NIDCR · INTERNATIONAL AGENCY FOR RES ON CANCER · PI HASHIBE, MIA · 2005 to 2006
$223k
International Head and Neck Cancer ConsortiumR03CA113157 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI HASHIBE, MIA · 2004 to 2005
$118k
HELICOBACTER PYLORI MALNUTRITION AND GASTRIC CANCERR03CA077954 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1997 to 1998
–
NCI NIH HHS P50 CA090388NCI NIH HHS R01 CA078609NCI NIH HHS R01 CA100679NCI NIH HHS R03 CA077954NCI NIH HHS R03 CA113157NCI NIH HHS T32 CA009142NCI NIH HHS U01 CA096134NIDA NIH HHS R01 DA011386NIDCR NIH HHS R03 DE016611NIEHS NIH HHS P30 ES010126NIEHS NIH HHS R21 ES011667
6 · The paper itself

Abstract

Food and nutrition play an important role in head and neck cancer (HNC) etiology; however, the role of carotenoids remains largely undefined. We explored the relation of HNC risk with the intake of carotenoids within the International Head and Neck Cancer Epidemiology Consortium. We pooled individual-level data from 10 case-control studies conducted in Europe, North America, and Japan. The analysis included 18,207 subjects (4414 with oral and pharyngeal cancer, 1545 with laryngeal cancer, and 12,248 controls), categorized by quintiles of carotenoid intake from natural sources. Comparing the highest with the lowest quintile, the risk reduction associated with total carotenoid intake was 39 % (95 % CI 29-47 %) for oral/pharyngeal cancer and 39 % (95 % CI 24-50 %) for laryngeal cancer. Intakes of β-carotene equivalents, β-cryptoxanthin, lycopene, and lutein plus zeaxanthin were associated with at least 18 % reduction in the rate of oral and pharyngeal cancer (95 % CI 6-29 %) and 17 % reduction in the rate of laryngeal cancer (95 % CI 0-32 %). The overall protective effect of carotenoids on HNC was stronger for subjects reporting greater alcohol consumption (p < 0.05). The odds ratio for the combined effect of low carotenoid intake and high alcohol or tobacco consumption versus high carotenoid intake and low alcohol or tobacco consumption ranged from 7 (95 % CI 5-9) to 33 (95 % CI 23-49). A diet rich in carotenoids may protect against HNC. Persons with both low carotenoid intake and high tobacco or alcohol are at substantially higher risk of HNC.

Indexed as

AdultAgedAged, 80 and overAntioxidantsCarcinoma, Squamous CellCarotenoidsCase-Control StudiesEpidemiologic StudiesEuropeFemaleHead and Neck NeoplasmsHumansJapanMiddle AgedSquamous Cell Carcinoma of Head and NeckUnited StatesAntioxidantsCarotenoidsCarotenoidsDietHead and neck cancerNutrients

Identifiers

PMID25930054
PMCPMC5552068
OpenAlexW2047074855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.